Dr Olumayokun Olajide is a Reader in Biochemical Pharmacology in the Department of Pharmacy, University of Huddersfield where he leads the natural products research group . He completed his PhD in Pharmacology of Natural Products at the University of Ibadan, Nigeria. This was followed by a Humboldt Postdoctoral Research Fellowship in the Pharmaceutical Biology Research Group, Department of Pharmacy, University of Munich, Germany. He was awarded a further Research Fellowship by the Humboldt Foundation to conduct research in the Neurochemistry Research Laboratories, University of Freiburg Medical School, Germany where he carried out research on natural products which modulate neuroinflammatory signalling pathways. His research programme focuses on the Molecular Pharmacology of Phytochemicals with anti-inflammatory activity and has authored more than 50 publications in this field. He is currently investigating phytochemicals which inhibit neuroinflammation as potential leads in the discovery of new therapeutics for Alzheimer’s disease. His pioneering study on the potential benefits of pomegranate in Alzheimer’s disease has resulted in an ongoing human intervention study. Dr Olajide is on the editorial board of Evidence-Based Complementary and Alternative Medicine (eCAM).